| |
| |
|
| Insider
Information: |
Higgins John L |
| Relationship: |
Director |
| City: |
Palo Alto |
| State: |
CA |
| |
|
| Insider
Summary: |
|
|
|
|
Companies Owned : |
3 |
|
| Direct
Shares |
2,806,928 |
|
|
Indirect Shares
|
0 |
|
|
| Direct
Value |
$42,361,605 |
|
|
|
Indirect Value
|
$0 |
|
|
| Total
Shares |
2,806,928 |
|
|
| Total
Value |
$42,361,605 |
|
|
|
|
|
|
|
|
Historical
Performance :
Based on 6 Month Return Percentages |
Buys
|
Sells
|
|
Total
Filings :
|
0
|
10
|
|
Stock
price went up :
|
0
|
5
|
| Stock
price went down : |
0
|
5
|
| |
|
|
|
Gain/Loss Ratio : |
0.0
|
0.0
|
| Percentage
Gain/Loss : |
0.0%
|
 -30.2%
|
| |
|
|
|
|
|
Holdings
:
| Menu |
Company Name |
Ticker |
Relation |
Direct Date |
Direct Shares |
Indirect Date |
Indirect Shares |
Total Value Sold  |
 |
Ligand Pharmaceuticals Inc |
LGND |
Director |
2022-12-28 |
417,695 |
2007-02-01 |
0 |
Premium* |
|
|
Techne Corp |
TECH |
Director |
2023-10-26 |
36,608 |
2013-10-31 |
0 |
Premium* |
|
|
OmniAb, Inc |
OABI |
Director |
2024-01-30 |
2,352,625 |
2022-11-01 |
0 |
Premium* |
|
|
|
|
|
|
|
|
|
|
|
Records found :
25 |
Free Registration Required For Full Results. Limit: 25
|
 |
Download |
Page 1 of 1
|
| Ticker |
Company Name |
Relation |
Off-Dir-10% |
Trans. Date |
Form |
Action |
Price |
Mkt Value |
D/I |
Shares |
Holdings |
Rank
|
|
|
| 3m +/- |
|
|
Form |
| OABI |
OmniAb, Inc |
Director |
– • – |
2024-01-30 |
4 |
OE |
$0.00 |
$0 |
D/D |
13,173 |
2,352,625 |
0 |
- |
|
| TECH |
Techne Corp |
Director |
– • – |
2023-10-26 |
4 |
A |
$0.00 |
$0 |
D/D |
1,625 |
36,608 |
0 |
- |
|
| OABI |
OmniAb, Inc |
Director |
– • – |
2023-05-23 |
4 |
S |
$4.05 |
$36,450 |
D/D |
(9,000) |
2,462,686 |
0 |
% |
|
| OABI |
OmniAb, Inc |
Director |
– • – |
2023-05-23 |
4 |
OE |
$3.68 |
$33,120 |
D/D |
9,000 |
2,471,686 |
0 |
- |
|
| OABI |
OmniAb, Inc |
Director |
– • – |
2023-05-19 |
4 |
OE |
$3.68 |
$3,680 |
D/D |
1,000 |
2,463,686 |
0 |
- |
|
| OABI |
OmniAb, Inc |
Director |
– • – |
2023-05-19 |
4 |
S |
$4.05 |
$4,050 |
D/D |
(1,000) |
2,462,686 |
0 |
% |
|
| OABI |
OmniAb, Inc |
Director |
– • – |
2023-05-18 |
4 |
OE |
$3.68 |
$184,000 |
D/D |
50,000 |
2,512,686 |
0 |
- |
|
| OABI |
OmniAb, Inc |
Director |
– • – |
2023-05-18 |
4 |
S |
$3.89 |
$194,500 |
D/D |
(50,000) |
2,462,686 |
0 |
% |
|
| TECH |
Techne Corp |
Director |
– • – |
2023-04-28 |
4 |
D |
$79.88 |
$349,635 |
D/D |
(4,377) |
34,983 |
0 |
- |
|
| TECH |
Techne Corp |
Director |
– • – |
2023-04-28 |
4 |
OE |
$21.85 |
$349,600 |
D/D |
16,000 |
39,360 |
0 |
- |
|
| OABI |
OmniAb, Inc |
Director |
– • – |
2023-01-30 |
4 |
A |
$0.00 |
$0 |
D/D |
39,517 |
2,462,686 |
0 |
- |
|
| OABI |
OmniAb, Inc |
Director |
– • – |
2023-01-04 |
4 |
A |
$3.23 |
$186,704 |
D/D |
57,803 |
2,339,452 |
0 |
- |
|
| OABI |
OmniAb, Inc |
Director |
– • – |
2022-12-28 |
4 |
A |
$3.66 |
$94,845 |
D/D |
25,914 |
2,397,255 |
0 |
- |
|
| LGND |
Ligand Pharmaceuticals In... |
Director |
– • – |
2022-12-28 |
4 |
D |
$66.29 |
$350,608 |
D/D |
(5,289) |
417,695 |
0 |
- |
|
| LGND |
Ligand Pharmaceuticals In... |
Director |
– • – |
2022-12-16 |
4 |
AS |
$61.87 |
$618,657 |
D/D |
(10,000) |
422,984 |
0 |
% |
|
| LGND |
Ligand Pharmaceuticals In... |
Director |
– • – |
2022-12-12 |
4 |
D |
$64.80 |
$255,571 |
D/D |
(3,944) |
432,984 |
0 |
- |
|
| LGND |
Ligand Pharmaceuticals In... |
Director |
– • – |
2022-12-12 |
4 |
OE |
$12.78 |
$255,600 |
D/D |
20,000 |
436,928 |
0 |
- |
|
| LGND |
Ligand Pharmaceuticals In... |
Chief Executive Officer |
• • – |
2022-11-30 |
4 |
D |
$72.90 |
$714,639 |
D/D |
(9,803) |
416,928 |
0 |
- |
|
| LGND |
Ligand Pharmaceuticals In... |
Chief Executive Officer |
• • – |
2022-11-18 |
4 |
OE |
$12.78 |
$127,800 |
D/D |
10,000 |
426,731 |
0 |
- |
|
| LGND |
Ligand Pharmaceuticals In... |
Chief Executive Officer |
• • – |
2022-11-17 |
4 |
AS |
$78.32 |
$783,173 |
D/D |
(10,000) |
416,731 |
0 |
% |
|
| OABI |
OmniAb, Inc |
Director |
– • – |
2022-11-02 |
4 |
OE |
$2.52 |
$621,553 |
D/D |
246,648 |
2,423,169 |
0 |
- |
|
| OABI |
OmniAb, Inc |
Director |
– • – |
2022-11-01 |
4 |
A |
$0.00 |
$0 |
D/D |
2,176,521 |
2,176,521 |
0 |
- |
|
| LGND |
Ligand Pharmaceuticals In... |
Chief Executive Officer |
• • – |
2022-11-01 |
4 |
A |
$0.00 |
$0 |
D/D |
45,922 |
424,731 |
0 |
- |
|
| OABI |
OmniAb, Inc |
Director |
– • – |
2022-11-01 |
4/A |
A |
$0.00 |
$0 |
D/D |
2,427,861 |
2,603,965 |
0 |
- |
|
| TECH |
Techne Corp |
|
– • – |
2022-10-27 |
4 |
A |
$0.00 |
$0 |
D/D |
338 |
5,840 |
0 |
- |
|
25 Records found
|
1
|
Page 1 of 1 |
| |
Free Registration Required For Full Results. Limit: 25
|
|
| |
Transaction Code Key: |
Ownership Code Key |
| |
B |
- Buy |
AB |
- Automatic Buy |
D |
- Direct Ownership |
| |
S |
- Sell |
AS |
- Automatic Sell |
I |
- Indirect Ownership |
|
OE |
- Options Exercised |
A |
- Aquired |
| |
IO |
- Initital Ownership |
D |
- Disposed |
| |
|
|
|
|
|
